In Person Special Seminar: Exercise in a Pill: A Chemist Approach and Drugging the S1P Pathway; and a Discussion of the Virginia Tech Center for Drug Discovery
Webster L. Santos, Ph.D.
Professor
Agnes and Cliff Lilly Fellow of Drug Discovery
Department of Chemistry
College of Science
Director, Center for Drug Discover
Virginia Tech
In Person Seminar: Connexin 43: Exercise in a Pill: A Chemist Approach and Drugging the S1P Pathway; and a Discussion of the Virginia Tech Center for Drug Discovery
Date: Feb. 22, 2023
Time: 1 p.m.
About this Seminar
In this presentation, Dr. Santos will highlight his team’s investigations on developing small molecule protonophores selective for mitochondria as potential treatment for obesity and fatty liver disease. The goal is to develop molecules that increase energy expenditure without the need for exercise. On the next part, Dr. Santos will discuss developing inhibitors of proteins in the sphingosine-1-phosphate (S1P) pathway for the treatment of multiple sclerosis and chronic kidney disease. S1P is an endogenous signaling molecule that functions as a chemotactic agent that is important in inflammation, fibrosis, and cancer. In both programs, the medicinal chemistry approach, assay development, and in vivo studies will be presented. Finally, he will discuss the VT Center for Drug Discovery and potential collaborations.
You May Also Be Interested In...
-
Home ItemInheriting Chromatin Domains in Mammals and the Mechanisms Involved , home
Sept. 5, 2025, 11:00 a.m. | Thelma Escobar, Ph.D., Assistant Professor, Department of Biochemistry, Institute for Stem Cell & Regenerative Medicine, University of Washington | Co-Sponsored by the Fralin Biomedical Research Institute and Cancer Research Center — D.C.
-
Home ItemFlow Induced Endothelial Planar Polarity for Signaling Regulation , home
Sept. 19, 2025, 11:00 a.m. | Julia Mack, Ph.D., Assistant Adjunct Professor, David Geffen School of Medicine, Division of Cardiology, University of California Los Angeles | Co-Sponsored by the Fralin Biomedical Research Institute Center for Vascular and Heart Research
-
Home ItemMaury Strauss Distinguished Public Lecture , home
Sept. 18, 2025, 5:30 p.m. (Reception at 5 p.m.) | Robert Gourdie, Ph.D., FAHA, AIMBE, Heywood Fralin Professor and Director, Center for Vascular and Heart Research, Fralin Biomedical Research Institute; Professor, Department of Biomedical Engineering and Mechanics, Virginia Tech College of Engineering; Elected Member, National Academy of Inventors | Maury Strauss Distinguished Public Lecture
-
Home ItemThe Bitter Truth: Alcohol Use and Its Effects on Chemosensory Function , home
Oct. 3, 2025, 11:00 a.m. | Paule Valery Joseph, Ph.D., Lasker Clinical Research Scholar, NIH Distinguished Scholar; Acting Chief, Section of Sensory Science and Metabolism Unit, Co-Director of the National Smell and Taste Center, National Institute on Deafness and Other Communication Disorders; National Institute of Alcohol Abuse and Alcoholism, National Institutes of Health | Co-Sponsored by the Fralin Biomedical Research Institute Center for Health Behaviors Research and Addiction Recovery Research Center
-
Home ItemOrganization and Control of Hippocampal Networks , home
Oct. 17, 2025, 11:00 a.m. | Ivan Soltesz, Ph.D., James R. Doty Professor of Neurosurgery and Neurosciences, Stanford University | Co-Sponsored by the Fralin Biomedical Research Institute Center for Neurobiology Research
-
Home ItemThinking the Right Thoughts , home
Oct. 31, 2025, 11 a.m. | Nathaniel Daw, Ph.D., Professor, Computational and Theoretical Neuroscience, Department of Psychology, Princeton University | Co-Sponsored by the Fralin Biomedical Research Institute Center for Human Neuroscience Research